Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Anissa Abi-Dargham, MD
JCP
Insight videos
Emerging Treatments in Schizophrenia Video
February 17, 2022
In this video, 3 experts discuss the challenge of treating schizophrenia with the current medications, which target blockade of dopaminergic receptors, and explore 4 new medications (ulotaront, KarXT, CVL-231,...
Christoph U. Correll
,
Anissa Abi-Dargham
,
Oliver Howes
JCP
InfoPacks
Emerging Treatments in Schizophrenia
February 15, 2022
Experts discuss the brain circuits involved in schizophrenia, the current medications, and new agents in phase 3 trials that do not directly block postsynaptic D2 receptors. Phase 2 data...
Christoph U. Correll
,
Anissa Abi-Dargham
,
Oliver Howes
JCP
Educational Activity
Schizophrenia: Overview and Dopamine Dysfunction
November 24, 2014
Anissa Abi-Dargham
JCP
Commentary
Schizophrenia: The Role of Dopamine and Glutamate
February 19, 2014
Anissa Abi-Dargham
,
Jonathan M. Meyer
JCP
Academic Highlights
Optimizing Pharmacotherapy to Maximize Outcome in Schizophrenia
January 15, 2005
John M. Kane
,
Anissa Abi-Dargham
,
Peter J. Weiden
, et al
